Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-100631
Filing Date
2024-08-26
Accepted
2024-08-26 17:40:27
Documents
2
Period of Report
2024-08-26

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1625
2 EX-24.1 ck0001768446-ex24_1.htm EX-24.1 18044
  Complete submission text file 0000950170-24-100631.txt   21166
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Issuer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Kaplan Brett (Reporting) CIK: 0001778763 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40708 | Film No.: 241242614